Louisiana State Employees Retirement System Makes New Investment in DENTSPLY SIRONA Inc. $XRAY

Posted by Stanley Muller on Jul 7th, 2026

Louisiana State Employees Retirement System purchased a new stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 57,900 shares of the medical instruments supplier’s stock, valued at approximately $672,000.

A number of other institutional investors and hedge funds also recently bought and sold shares of XRAY. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in shares of DENTSPLY SIRONA in the first quarter valued at $26,000. Eurizon Capital SGR S.p.A. acquired a new stake in DENTSPLY SIRONA in the 4th quarter valued at about $26,000. Caitong International Asset Management Co. Ltd increased its position in DENTSPLY SIRONA by 337.9% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 2,750 shares of the medical instruments supplier’s stock valued at $35,000 after acquiring an additional 2,122 shares in the last quarter. Farther Finance Advisors LLC raised its stake in shares of DENTSPLY SIRONA by 119.1% in the fourth quarter. Farther Finance Advisors LLC now owns 3,773 shares of the medical instruments supplier’s stock worth $43,000 after acquiring an additional 2,051 shares during the last quarter. Finally, Performa Ltd US LLC lifted its position in shares of DENTSPLY SIRONA by 116.1% during the fourth quarter. Performa Ltd US LLC now owns 4,250 shares of the medical instruments supplier’s stock worth $49,000 after purchasing an additional 2,283 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently weighed in on the stock. Weiss Ratings lowered shares of DENTSPLY SIRONA from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, May 6th. Mizuho reduced their price objective on DENTSPLY SIRONA from $16.00 to $14.00 and set a “neutral” rating on the stock in a report on Wednesday, May 6th. UBS Group decreased their price objective on DENTSPLY SIRONA from $18.00 to $17.00 and set a “buy” rating on the stock in a research report on Thursday, May 7th. Citigroup began coverage on DENTSPLY SIRONA in a research note on Wednesday, April 15th. They issued a “sell” rating and a $10.00 target price for the company. Finally, Barclays dropped their target price on DENTSPLY SIRONA from $12.00 to $9.00 and set an “underweight” rating for the company in a research report on Thursday, June 4th. Three analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $13.55.

View Our Latest Stock Report on XRAY

DENTSPLY SIRONA Trading Down 1.3%

Shares of DENTSPLY SIRONA stock traded down $0.15 during trading on Tuesday, reaching $12.16. 234,719 shares of the company were exchanged, compared to its average volume of 5,007,478. The business has a 50-day moving average price of $10.58 and a 200-day moving average price of $11.65. The firm has a market capitalization of $2.44 billion, a price-to-earnings ratio of -3.87, a P/E/G ratio of 1.39 and a beta of 0.89. The company has a quick ratio of 0.98, a current ratio of 1.53 and a debt-to-equity ratio of 1.52. DENTSPLY SIRONA Inc. has a twelve month low of $9.40 and a twelve month high of $17.09.

DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) last released its quarterly earnings data on Tuesday, May 5th. The medical instruments supplier reported $0.27 earnings per share for the quarter, missing the consensus estimate of $0.28 by ($0.01). The firm had revenue of $880.00 million for the quarter, compared to the consensus estimate of $841.80 million. DENTSPLY SIRONA had a positive return on equity of 18.83% and a negative net margin of 17.06%.The firm’s revenue was up .1% compared to the same quarter last year. During the same period in the previous year, the business earned $0.43 EPS. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. Sell-side analysts anticipate that DENTSPLY SIRONA Inc. will post 1.42 EPS for the current fiscal year.

Insider Transactions at DENTSPLY SIRONA

In other news, Director Michael J. Barber acquired 15,175 shares of the stock in a transaction that occurred on Thursday, June 11th. The stock was acquired at an average price of $9.88 per share, for a total transaction of $149,929.00. Following the transaction, the director directly owned 55,943 shares in the company, valued at approximately $552,716.84. This represents a 37.22% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this link. Also, Director Brian T. Gladden acquired 9,985 shares of the company’s stock in a transaction that occurred on Monday, June 15th. The shares were acquired at an average cost of $10.02 per share, for a total transaction of $100,049.70. Following the purchase, the director directly owned 61,849 shares in the company, valued at $619,726.98. This trade represents a 19.25% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have bought a total of 35,160 shares of company stock valued at $351,179 over the last three months. 0.46% of the stock is currently owned by corporate insiders.

DENTSPLY SIRONA Company Profile

(Free Report)

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.